Seeing Is Believing
Currently out of the existing stock ratings of John Walsh, 96 are a HOLD (35.29%), 162 are a BUY (59.56%), 14 are a SELL (5.15%).
Analyst John Walsh, currently employed carries an average stock price target met ratio of 63.49% that have a potential upside of 23.21% achieved within 224 days. Previously, John Walsh worked at CREDIT SUISSE.
John Walsh’s has documented 570 price targets and ratings displayed on 36 stocks. The coverage was on Industrials, Technology, Basic Materials, Healthcare sectors.
Most recent stock forecast was given on PNT, POINT Biopharma Global at 04-Oct-2023.
Analyst best performing recommendations are on GTLS (CHART INDUSTRIES).
The best stock recommendation documented was for GTLS (CHART INDUSTRIES) at 10/13/2020. The price target of $80 was fulfilled within 1 day with a profit of $4.69 (6.23%) receiving and performance score of 62.28.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Sell
117
$-21.84 (-15.73%)
116
1 months 6 days ago
14/19 (73.68%)
$-15.88 (-11.95%)
169
Hold
141
$2.16 (1.56%)
140
6 months 8 days ago
4/8 (50%)
$12.89 (10.06%)
260
Hold
116
$-22.84 (-16.45%)
122
9 months 30 days ago
10/13 (76.92%)
$18.21 (18.62%)
277
Hold
100
$-38.84 (-27.97%)
128
10 months 12 days ago
2/2 (100%)
$2.56 (2.63%)
208
127
$-11.84 (-8.53%)
120
1 years 1 months 4 days ago
22/23 (95.65%)
$13.29 (11.69%)
248
What Year was the first public recommendation made by John Walsh?